NCT04919629
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Ovarian Serous Adenocarcinoma
Explore clinical trials studying Ovarian Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.
26 public trials
2 recruiting studies
Ovarian Serous Adenocarcinoma trial results
NCT04575935
- Conditions
- Adnexal Diseases, Advanced Ovarian Carcinoma, Endocrine Gland Neoplasms, +39 more
- Locations
-
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Cleveland Clinic Foundation - Florida Weston, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT07068178
- Conditions
- HIPEC, Ovarian Serous Adenocarcinoma
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
Active, not recruiting
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
NCT05415709
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +47 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
NCT01116648
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +21 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard Fort Wayne, Indiana, United States
Active, not recruiting
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
NCT02068794
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +39 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, not recruiting
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02502266
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Active, not recruiting
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT01167712
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +50 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
Active, not recruiting
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- Omega Hospitals Visakhapatnam, Andhra Pradesh, India
- King George Hospital Visakhapatnam, Andhra Pradesh, India
- Himalaya Cancer Hospital and Research Institute Vadodara, Gujarat, India
- Kailash Cancer Hospital and Research Centre Vadodara, Gujarat, India
Active, not recruiting
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
- Locations
-
- Honor Health Phoenix, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- John Muir Health Clinical Research Center Concord, California, United States
- Kaiser Permanente Southern California Irvine, California, United States